WRBY vs. EYE, STAA, RXST, BLTE, CGEM, PRTA, GYRE, IRWD, SYRE, and PHR
Should you be buying Warby Parker stock or one of its competitors? The main competitors of Warby Parker include National Vision (EYE), STAAR Surgical (STAA), RxSight (RXST), Belite Bio (BLTE), Cullinan Oncology (CGEM), Prothena (PRTA), Gyre Therapeutics (GYRE), Ironwood Pharmaceuticals (IRWD), Spyre Therapeutics (SYRE), and Phreesia (PHR). These companies are all part of the "medical" sector.
National Vision (NASDAQ:EYE) and Warby Parker (NYSE:WRBY) are both small-cap medical companies, but which is the superior investment? We will compare the two businesses based on the strength of their profitability, community ranking, institutional ownership, media sentiment, dividends, risk, analyst recommendations, earnings and valuation.
93.2% of Warby Parker shares are owned by institutional investors. 2.1% of National Vision shares are owned by company insiders. Comparatively, 26.9% of Warby Parker shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.
National Vision currently has a consensus price target of $21.00, indicating a potential upside of 42.28%. Warby Parker has a consensus price target of $16.50, indicating a potential upside of 11.56%. Given Warby Parker's higher possible upside, equities analysts plainly believe National Vision is more favorable than Warby Parker.
Warby Parker has lower revenue, but higher earnings than National Vision. Warby Parker is trading at a lower price-to-earnings ratio than National Vision, indicating that it is currently the more affordable of the two stocks.
National Vision received 229 more outperform votes than Warby Parker when rated by MarketBeat users. Likewise, 65.89% of users gave National Vision an outperform vote while only 32.88% of users gave Warby Parker an outperform vote.
In the previous week, Warby Parker had 2 more articles in the media than National Vision. MarketBeat recorded 25 mentions for Warby Parker and 23 mentions for National Vision. Warby Parker's average media sentiment score of 0.66 beat National Vision's score of 0.17 indicating that National Vision is being referred to more favorably in the media.
National Vision has a net margin of -3.10% compared to National Vision's net margin of -9.44%. Warby Parker's return on equity of 3.69% beat National Vision's return on equity.
National Vision has a beta of 1.47, suggesting that its stock price is 47% more volatile than the S&P 500. Comparatively, Warby Parker has a beta of 1.64, suggesting that its stock price is 64% more volatile than the S&P 500.
Summary
National Vision and Warby Parker tied by winning 9 of the 18 factors compared between the two stocks.
Get Warby Parker News Delivered to You Automatically
Sign up to receive the latest news and ratings for WRBY and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding WRBY and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Warby Parker Competitors List
Related Companies and Tools
